轻度至中度性结肠炎患者的药物优化:全球调查
Ferdinando D'Amico1, Vipul Jairath2, Kristine Paridaens3
1Department of Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, 20132 Milan, Italy.
Journal of clinical medicine
|May 11, 2024
概括
医生普遍接受性结肠炎 (UC) 的指导方针,优先考虑内镜缓解. 然而,一些临床医生犹不决,仅根据便calprotectin或成像来调整治疗,这表明在轻度至中度UC管理中可以进行优化.
科学领域:
- 胃肠病学 胃肠病学
- 临床实践 临床实践
- 炎症性肠道疾病研究研究
背景情况:
- 轻度至中度的性结肠炎 (UC) 管理存在挑战,尽管存在指导方针,但治疗优化并非标准化.
- 调查UC患者护理中的当前医生实践对于确定改进领域至关重要.
研究的目的:
- 调查经验丰富的炎症性肠病 (IBD) 医生,了解他们对轻度至中度UC的管理和治疗策略.
- 了解患者监测,治疗优化,随访,决策和UC患者缓和等现有实践.
主要方法:
- 在2023年6月至7月期间,向全球IBD经验丰富的医生分发了一项匿名多选项调查.
- 该调查收集了222位胃肠科医生和其他专家关于他们对轻度至中度UC的方法的数据.
主要成果:
- 口服和直肠5-aminosalicylic acid (5-ASA) 的组合是首选的初始优化策略.
- 布德索尼德MMX和全身类固醇在对5-ASA无反应的患者中是最受欢迎的.
- 治疗决策主要依赖于内镜和临床活动,不太重视便calprotectin或仅仅是成像.
结论:
- 目前的临床实践通常与轻度至中度UC的既定指南保持一致.
- 内镜缓解是治疗的主要目标,其次是临床缓解.
- 医生表示使用便calprotectin和肠道超声波来调整治疗的挑战.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
136
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
136
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115
Peptic Ulcer Disease IV: Management
89
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
89
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
158
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
158


